Change Theme
Mint
Fri, Aug 30, 2024
Alnylam Dealt Setback in Quest to Expand Heart Drug’s Uses
Alnylam Pharmaceuticals Inc. shares fell after a trial of its drug to treat a deadly form of heart disease fell short of investors’ expectations.